Why Lupin's stock is gaining for the 2nd day running

Business Nov 10, 2025

Lupin's stock climbed 3% on Monday, hitting ₹2,027, after the pharma company posted strong Q2 numbers and analysts raised their price targets.
This marks two days in a row of gains for Lupin.

Lupin's stellar Q2 results

Lupin's Q2 net profit shot up 73% to ₹1,478 crore, with revenue rising 24% to ₹7,048 crore.
The US market was a big driver—sales there jumped 47%, reaching their highest since 2017.

Price targets raised as US market sales soar

Analysts are feeling upbeat thanks to Lupin's new US product launches and better margins.
The company now expects its US revenue to top $1 billion in FY26 and plans over 15 new product filings by FY26.
Jefferies has boosted its price target, seeing more growth ahead.